- Biotechnology
- Healthcare
Vertex Pharmaceuticals Incorporated
VRTX · US ·
NASDAQ
468.45
USD
+2.49
(0.53%)
-
-1.90
EPS
-
-246.80
P/E
-
121B
MARKET CAP
-
0.00%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | -1.79 | 3.94 | 22.7 | 27.1 | 25.9 | 28.9 | 78.47% |
| Avg. Estimate | -1.9 | 0.452 | 16.5 | 18.9 | 23.1 | 25.8 | 73.16% |
| Low Estimate | -2.13 | -0.336 | 13.7 | 15.2 | 21.9 | 24.3 | 68.13% |
| No. Of Analysts | 19 | 16 | 17 | 13 | 5 | 8 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 10.4B | 10.9B | 13.7B | 14.3B | 15.3B | 16.5B | 9.69% |
| Avg. Estimate | 10.3B | 10.8B | 11.8B | 13B | 14B | 15.1B | 7.87% |
| Low Estimate | 10.3B | 10.7B | 11.1B | 12.5B | 13.4B | 14.4B | 7.08% |
| No. Of Analysts | 23 | 19 | 23 | 23 | 19 | 13 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | -392M | 1.03B | 5.92B | 7.05B | 6.76B | 7.52B | 84.19% |
| Avg. Estimate | -490M | 118M | 4.28B | 4.98B | 6.03B | 6.71B | 73.46% |
| Low Estimate | -588M | -87.6M | 3.57B | 3.95B | 5.69B | 6.34B | 66.47% |
| No. Of Analysts | 23 | 19 | 23 | 23 | 19 | 13 |